Study looks at pediatric firearm-related eye injuries in the U.S.

(HealthDay)—A quarter of all U.S. ocular firearm injuries occur within the pediatric population, according to a study published online Oct. 10 in JAMA Ophthalmology. Rebecca Weiss, M.D., of the Montefiore Medical Center in Bronx, New York, and colleagues used data collected from the National Trauma Data Bank to analyze firearm-related ocular injuries (1,972 injuries) for pediatric patients (younger than 21 […]

Continue reading »

Drug treats inflammation associated with genetic heart disease that can be deadly in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it’s usually due to arrhythmogenic cardiomyopathy (ACM), an inherited heart disease. Now, Johns Hopkins researchers have shed new light on the role of the immune system in the progression of ACM and, in the process, discovered a new drug that might help prevent ACM disease symptoms […]

Continue reading »

Daily exposure to blue light may accelerate aging, even if it doesn’t reach your eyes

Prolonged exposure to blue light, such as that which emanates from your phone, computer and household fixtures, could be affecting your longevity, even if it’s not shining in your eyes. New research at Oregon State University suggests that the blue wavelengths produced by light-emitting diodes damage cells in the brain as well as retinas. The study, published today in Aging […]

Continue reading »

Indigenous Australians’ vaccination rates too low and not improving

A new UNSW study has found that most adult Indigenous Australians are not receiving free flu and pneumococcal vaccinations. We need urgent action to reverse declining targeted flu and pneumococcal vaccination rates among adult Indigenous Australians, according to a new UNSW study. The study—published today in the Australian and New Zealand Journal of Public Health – found that adult Indigenous […]

Continue reading »

Improving cancer screening: what does the latest review recommend?

Screening people for cancer saves thousands of lives every year. And these programmes will play a vital role in achieving NHS England’s ambition to diagnose 3 in 4 cancers early by 2028. But there’s room for improvement. After a difficult period for cancer screening programmes in England, former National Cancer Director Sir Mike Richards was tasked with reviewing the programmes […]

Continue reading »

How to enable light to switch on and off therapeutic antibodies

When antigens such as a virus or bacteria invade our body, the immune system springs into action: it creates antibodies that stick to the antigens so that they can identify and destroy the intruders. Did you know that these Y-shaped proteins, AKA antibodies, have been revolutionizing the treatment of cancer, inflammatory disease and autoimmune disease, and many others? Therapeutic antibodies […]

Continue reading »

Bioelectronic implant could prevent opioid deaths

Researchers are developing a novel, implantable device that can sense the effects of a potentially fatal level of ingested opioids and then automatically and immediately deliver a life-saving dose of naloxone. The interdisciplinary research team, led by Northwestern University and Washington University at St. Louis, recently received a grant from the National Institutes of Health’s Helping to End Addiction Long-term […]

Continue reading »

Drug reduces risk of pneumonia in newborn mice

The underdeveloped lungs and immune systems of premature babies put them at high risk of potentially deadly pneumonia. Now, a study from Washington University School of Medicine in St. Louis has found, in mice, that an inhaled drug promotes the development of lung immunity and reduces the risk of pneumonia. The findings, published Aug. 14 in Science Advances, suggest that […]

Continue reading »

Second Ebola vaccine to be used in DR Congo next month

Doctors will use a second Ebola vaccine from November in three eastern provinces in the Democratic Republic of Congo to fight the deadly virus, medical officials said Sunday. “It’s time to use the new Ad26-ZEBOV-GP vaccine, manufactured by Johnson & Johnson’s Belgian subsidiary,” said Dr. Jean-Jacques Muyembe, who leads the national anti-Ebola operation in the DRC. It will arrive in […]

Continue reading »

New test diagnoses Lyme disease within 15 minutes

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications. Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western […]

Continue reading »
1 43 44 45 46 47 202